Ritter Pharma (@RitterPharma) header
Ritter Pharma (@RitterPharma) profile picture

Ritter Pharma

@RitterPharma

Developing the first FDA-approved treatment for lactose intolerance. #lactoseintolerance #microbiome #biotech $RTTR

 Los Angeles, CA
ritterpharmaceuticals.com/
Joined April 2015
  • Tweets81
  • Following323
  • Followers301
17Media
Photo by Ritter Pharma (@RitterPharma)Photo by Ritter Pharma (@RitterPharma)Photo by Ritter Pharma (@RitterPharma)Photo by Ritter Pharma (@RitterPharma)Photo by Ritter Pharma (@RitterPharma)Photo by Ritter Pharma (@RitterPharma)Photo by Ritter Pharma (@RitterPharma)Photo by Ritter Pharma (@RitterPharma)Photo by Ritter Pharma (@RitterPharma)Photo by Ritter Pharma (@RitterPharma)
Ritter Pharmaceuticals Appoints Esteemed Gastroenterologist Anthony J. Lembo, M.D. to its Medical Advisory Board. #ritterpharma #anthonyLembo #Gastroenterology ritterpharmaceuticals.com/ri…
2
1
Hosting a conference call on August 7, 2019 @1:30pm ET to Highlight Recent Lactose Intolerance Market Research Findings! Participants may register at any time to gain access: dpregister.com/10134115 #RitterPharma #lactoseintolerance #phase3
Image from Ritter Pharma (@RitterPharma)
This is a friendly reminder, we are excited to host a conference call to present new insights and market research on the lactose intolerance market. The call will be held on August 7, 2019 at 1:30 PM ET/ 10:30 AM PT. #RitterPharma #Phase3 #Lactoseintolerance
Image from Ritter Pharma (@RitterPharma)
Hosting a conference call on August 7, 2019 @1:30pm ET to Highlight Recent Lactose Intolerance Market Research Findings! Learn more: lnkd.in/gZ8F8Ax or register for the call: lnkd.in/gDzeyHz
Image from Ritter Pharma (@RitterPharma)
1
1
1
Ritter Pharmaceuticals Announces Last Patient Last Visit in its Phase 3 “Liberatus” Clinical Trial of RP-G28 for Lactose Intolerance. #Ritterpharma #phase3 #lastpatient #lactoseintolerance ritterpharmaceuticals.com/ri…
1
Ritter Pharmaceuticals Provides Phase 3 Liberatus Clinical Trial and Regulatory Update #RitterPharma #Phase3 #clinicaltrials #regulatory ritterpharmaceuticals.com/ri…
Ritter Pharmaceuticals Shares New Market Research Illuminating the Life Challenges of a Lactose Intolerance Sufferer. #RitterPharma #Phase3 #lifechallenges #LactoseIntolerance ritterpharmaceuticals.com/ri…
1
1
1
Ritter Pharmaceuticals Completes Dosing of Last Patient in Pivotal 557-Subject Phase 3 Clinical Trial of RP-G28 in Patients with Lactose Intolerance. #RitterPharma #Phase3 #LastPatient #LactoseIntolerance ritterpharmaceuticals.com/ri…
1
4
Ritter Pharmaceuticals Completes Enrollment in Pivotal Phase 3 Clinical Trial of RP-G28 in Patients with Lactose Intolerance. #RitterPharma #Phase3 #Completes enrollment #Lactose #intolerance ritterpharmaceuticals.com/ri…
1
2
Dr. William Chey Highlights Unmet Medical Need of Lactose Intolerance and Potential for Phase 3 Drug Candidate RP-G28 in Expert Call Hosted by Ritter Pharmaceuticals. #RitterPharma @umfoodoc #Phase3 #Lactose Intolerant ritterpharmaceuticals.com/dr…
1
Ritter Pharmaceuticals to Host Expert Call with Dr. William Chey @umfoodoc on February 20, 2019. #Ritterpharma #Science #WilliamChey #Gastrointestinal #Rp-G28 ritterpharmaceuticals.com/ri….
Ritter Pharmaceuticals To Present at Noble Capital Markets’ Fifteenth Annual Investor/Equity Conference on January 28, 2019. #Ritterpharma #NobelCapitalMarkets #FDAAPPROVEDTREATMENT #Phase3 ritterpharmaceuticals.com/ri…
#RitterPharma Ritter Pharmaceuticals Reaches Halfway Mark for Enrollment in Pivotal Phase 3 Clinical Trial of RP-G28 in Patients with Lactose Intolerance. #HalfwayEnrollment #Phase3 #Lactoseintolerance ritterpharmaceuticals.com/ri…
1
#RitterPharma Ritter Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2018 and Recent Progress #Financialresults ritterpharmaceuticals.com/ri…
#Ritterpharma Ritter Pharmaceuticals Announces Closing of $6.0 Million At-Market Private Placement of Series B Convertible Preferred Stock and Warrants. ritterpharmaceuticals.com/ri…
1
2
@RitterPharma presents it’s poster presentation of its Phase 2b #Microbiome data at #ACG18 @AndrewRitter
Image from Ritter Pharma (@RitterPharma)
#RitterPharma Reports Financial Results for the Three and Six Months Ended June 30, 2018 and Recent Progress ritterpharmaceuticals.com/ri…
1
1
#RitterPharma will host a conference call today at 4:30 p.m. ET (1:30 p.m. PT) to discuss Phase 3 trial initiation. Details below. ritterpharmaceuticals.com/in…
1
4
#RitterPharma initiates first pivotal Phase 3 trial for RP-G28 for the treatment of lactose intolerance #LactoseIntolerance #Biotech #ClinicalTrials #Microbiome #MicroCap ritterpharmaceuticals.com/in…
1
#RitterPharma appoints Andrew J. Ritter to Chief Executive Officer #LactoseIntolerance #Biotech #Microbiome #MicroCap ritterpharmaceuticals.com/ch…
Load more